|
(PQ1) Cellular senescence as an initiating event in malignant transformation
|
1R21CA206013-01A1
|
$203,400
|
DAVID, GREGORY
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
(PQ11) Targeting STING in the context of chemoradiation therapy to overcome poor preexisting immunity in mouse models of pancreatic cancer.
|
5R01CA208644-02
|
$377,438
|
CRITTENDEN, MARKA
|
PROVIDENCE PORTLAND MEDICAL CENTER
|
|
(PQ4) Mutations in the histone chaperone DAXX drive pancreatic neuroendocrine tumors not ductal adenocarcinomas
|
5R21CA208463-02
|
$174,000
|
LOZANO, GUILLERMINA
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
(PQA-4) Organoid Omics To Detect And Defeat Ductal Pancreatic Cancer
|
5R01CA190092-04
|
$552,684
|
TUVESON, DAVID
|
COLD SPRING HARBOR LABORATORY
|
|
(PQB-3) Driver gene-induced inflammation in pancreatic cancer development
|
5R01CA184926-04
|
$765,544
|
JAFFEE, ELIZABETH
|
JOHNS HOPKINS UNIVERSITY
|
|
(PQD3)Molecular Profiles associated with Long-Term Survival in pancreas Cancer
|
5R01CA185357-04
|
$398,393
|
AHUJA, NITA
|
JOHNS HOPKINS UNIVERSITY
|
|
0021.0001 CG 425 METAVIVOR
|
261200800001E
|
$319,219,481
|
UNKNOWN, UNKNOWN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
1/2: Partnership to study racial/ethnic differences in GI cancer biology
|
3P20CA192994-03S1
|
$63,140
|
LI, ELLEN
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
1/2: Partnership to study racial/ethnic differences in GI cancer biology
|
5P20CA192994-03
|
$288,919
|
LI, ELLEN
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
2/2 Partnership to Study Racial/Ethnic Differences in GI Cancer Biology
|
5P20CA192996-03
|
$154,908
|
MCCOMBIE, WILLIAM
|
COLD SPRING HARBOR LABORATORY
|
|
2/2 SDSU/UCSD Cancer Center Comprehensive Partnership
|
5U54CA132384-08
|
$1,192,222
|
ARREDONDO, ELVA
|
SAN DIEGO STATE UNIVERSITY
|
|
A cell-based liquid biopsy approach for early pancreatic cancer detection
|
5F32CA196120-03
|
$57,066
|
BHAGWAT, NEHA
|
UNIVERSITY OF PENNSYLVANIA
|
|
A Clinical Validation Center for Early Detection of Pancreatic Cancer
|
5U01CA200468-02
|
$1,759,344
|
MAITRA, ANIRBAN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
A differentiation-based mechanism limiting pancreatic tumor initiation
|
5F30CA192819-03
|
$40,653
|
KRAH, NATHAN
|
UNIVERSITY OF UTAH
|
|
A Follow-up Study for Causes of Cancer in Black Women
|
2U01CA164974-07
|
$2,195,369
|
ROSENBERG, LYNN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
A Follow-up Study for Causes of Cancer in Black Women
|
5UM1CA164974-06
|
$639,740
|
ROSENBERG, LYNN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
A highly specific NIRF/PET probe for the detection of cancer and metastases
|
1R43CA210854-01A1
|
$224,958
|
Yang, Xinlin
|
IMOL RADIOPHARMACEUTICALS, LLC
|
|
A novel miR-198 replacement therapy for pancreatic cancer
|
5R01CA183984-03
|
$473,915
|
YAO, QIZHI
|
BAYLOR COLLEGE OF MEDICINE
|
|
A Prospective Investigation of the Oral Microbiome and Pancreatic Cancer
|
5U01CA187508-03
|
$590,572
|
PALMER, JULIE
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
A Scalable Blood-based Pancreatic Cancer Test for High-Risk Screening
|
1R43CA213863-01A1
|
$225,001
|
FREEDMAN, DAVID
|
NANOVIEW DIAGNOSTICS, INC.
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196-03152
|
$703,174
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-41S1
|
$125,000
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-41S2
|
$62,491
|
VONDERHEIDE, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-41
|
$7,810,244
|
VONDERHEIDE, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
|
Advanced Development and Validation of 3 Dimensional Spheroid Culture of Primary Cancer Cells using Nano3D Technology
|
5R33CA206949-02
|
$475,865
|
SPICER, TIMOTHY
|
SCRIPPS FLORIDA
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-04S1
|
$2,088,480
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
5U10CA180821-04
|
$11,145,123
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alternatively Spliced Tissue Factor and Pathobiology of Pancreatic Cancer
|
5R01CA190717-03
|
$276,298
|
BOGDANOV, VLADIMIR
|
UNIVERSITY OF CINCINNATI
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,094,457
|
Barr, Frederic
|
CCR (NCI)
|
|
Annexin A2 as a mediator of pancreatic cancer metastases
|
5R01CA169702-05
|
$336,150
|
ZHENG, LEI
|
JOHNS HOPKINS UNIVERSITY
|
|
Area A: In-Depth Proteome Mapping of the Tumor Microenvironment with Single-Cell Resolution
|
1R33CA225248-01
|
$1,744,991
|
KELLY, RYAN
|
BATTELLE PACIFIC NORTHWEST LABORATORIES
|
|
At the nexus of redox and signaling pathways: regulation of NAD+ kinase
|
1F31CA220750-01
|
$44,044
|
SCHILD, TANYA
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
ATBC Study
|
ZIA CP010195-03031
|
$1,161,432
|
N/A
|
DCEG (NCI)
|
|
ATDC Function in Human Pancreatic Adenocarcinoma
|
5R01CA131045-07
|
$368,125
|
SIMEONE, DIANE
|
UNIVERSITY OF MICHIGAN
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV-AIDS Research
|
ZIG BC 010856
|
$14,497,944
|
Custer, Mary
|
CCR (NCI)
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S1
|
$118,333
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S2
|
$118,875
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S3
|
$122,250
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S4
|
$250,002
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-11
|
$3,253,119
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Beyond apoptosis, Bcl-xL in tumor metastasis
|
1R01CA204916-01A1
|
$406,557
|
DU, YI-CHIEH NANCY
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$755,842
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Biochemical and molecular studies on NQO1. Design of less toxic Hsp90 inhibitors
|
5R01CA051210-25
|
$312,983
|
ROSS, DAVID
|
UNIVERSITY OF COLORADO DENVER
|
|
Biological Activity of Ras Oncogenes
|
5R01CA042978-31
|
$349,678
|
DER, CHANNING
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Biomarker validation for intraductal papillary mucinous neoplasms of the pancreas
|
5R01CA182076-04
|
$349,513
|
ALLEN, PETER
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis
|
ZIA BC 011334
|
$474,811
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Biophotonics to Couple Pancreatic with Upper GI Screening via Ultrathin Endoscopy
|
5R01CA183101-03
|
$634,023
|
BACKMAN, VADIM
|
NORTHWESTERN UNIVERSITY
|
|
Breaking the Obesity-Cancer Link: New Targets and Strategies
|
5R35CA197627-03
|
$762,608
|
HURSTING, STEPHEN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Building on the success of the adoptive immunotherapy of cancer
|
ZIA BC 010763
|
$1,562,883
|
Restifo, Nicholas
|
CCR (NCI)
|
|
Building protected data sharing networks to advance cancer risk assessment and treatment
|
1U24CA209996-01A1
|
$805,856
|
FOSTER, IAN
|
UNIVERSITY OF CHICAGO
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|